aluminium hydroxide or using water contaminated by aluminium for the preparation of dialysis fluid.1 2 We have noticed that the incidence of encephalopathy and spontaneous fractures in patients undergoing intermittent dialysis is unevenly distributed in the Trent Region.3-5 We present here further information on the composition of the water supplied to the homes of our patients and the results of tissue analyses.
Patients and methods
All patients with end-stage renal failure treated by intermittent haemodialysis at home under the care of the Sheffield renal unit were considered (202 patients). They included patients who subsequently received a renal transplant.
Three groups were selected from this population. Dialysis encephalopathy-Eleven patients developed a disease of the central nervous system for which no diagnosis other than dialysis encephalopathy was appropriate after full investigation. Seven had the typical syndrome of speech disturbance and myoclonic jerks slowly progressing to a mute paralytic state. Three patients, one of whom had fits for many months, developed rapid cerebral deterioration in association with generalised infection. One patient had suffered fits for many months with severe depression and weight loss, and he eventually died from inanition. In three patients the illness had begun a few weeks after the establishment of a well-functioning renal transplant. Seven of these patients also had multiple pathological fractures and nine died (see table I ).
Fracture-Twenty-one patients sustained a fracture after starting haemodialysis and before transplantation but had no brain disease. Eleven of these patients had multiple fractures.
No complications-This group comprised 36 patients who had undergone dialysis for at least four years without developing fractures or encephalopathy.
DIALYSIS TECHNIQUE
After several months' training in hospital all patients performed dialysis in their homes for three periods of six or seven hours each week. They used a Kiil, hollow-fibre, or coil dialyser with a surface area of about 1 M2n. The dialysate contained 1-6 mmol/1 (64 mg/ 100 ml) of calcium. All patients took 1-2 g of calcium carbonate daily and supplements of folic acid and intravenous saccharated iron oxide. Only patients with persistently high plasma phosphate concentrations were prescribed aluminium hydroxide, which they did not usually take enthusiastically. Patients who had histologically proved osteomalacia or serum calcium concentrations below 2 2 mmol/1 (8 8 Of the patients with encephalopathy, six had taken aluminium hydroxide and only one patient had received neither aluminium hydroxide nor water with a high aluminium concentration (table I) .
Three of the four specimens of bone from patients with encephalopathy (cases 6, 8, and 9) contained very large amounts of aluminium, but the aluminium content of brain from three patients with encephalopathy (3, 8, and 10) was not increased. Brain from two demented patients contained 1 mg/kg dry weight of manganese, and ashed bone from the same patients contained less than 1 mg/kg of manganese.
These values are similar to those in normal people.' 6 7 8 Concentrations of the other elements in bone, as determined by optical spectrography, were not raised in cases 8 and 9 except for tin, which was present in a concentration of 20-25 mg/kg dry weight compared with under 3 mg/kg in controls. Similarly, within the sensitivity limitations of the emission spectrographic method, no evidence for "abnormal" concentrations of other elements was found in brain from cases 8 and 9. There was no significant difference in the mean plasma phosphorus concentration between any of the groups except when the lower posttransplant figures were included in the patients with encephalopathy (table II) .
In view of these findings we coinpared two methods of removing aluminium and manganese from water. The results (table III) showed that a cation-exchange resin water softener did not remove aluminium or manganese consistently from water whereas a deioniser did. Dialysate prepared from a commercial solution of concentrated electrolytes and deionised water contained 0 03 mg/l of aluminium. bismuth, and possibly aluminium,9 cause encephalopathy, and the same metals also accumulate in bone. The occurrence of encephalopathy after successful transplantation and cessation of dialysis may be due to release of stored trace metal from bone as a result of immobilisation, secondary hyperparathyroidism, and the administration of large doses of prednisolone. This hypothesis is supported by the progress in case 2. This young woman underwent dialysis for two years and then developed encephalopathy about four weeks after receiving a renal transplant. She fractured several ribs spontaneously about the same time. Her encephalopathy began with fits but within four weeks she was mute and almost completely paralysed though conscious. She appeared moribund. Transplant function continued to be good and the dose of prednisolone was reduced. She then improved slowly for six months, but for the past year she has been in an unaltering state in which she is fully conscious, lucid, and speaking normally, though her mental faculties are mildly impaired. She has epilepsy controlled by drugs and has full use of her arms but cannot stand. Her electroencephalogram remains grossly abnormal and recent computerised tomography of the brain shows atrophy of the right cerebral hemisphere. We believe that she has now excreted her stored noxious trace element(s) but has permanent, residual, non-progressive brain damage. She is the only patient who has recovered to some degree from this disease.
The strong association between the occurrence of multiple fractures and encephalopathy2 5 10 and the similarity in their geographical distribution and in the composition of the water supplied to these patients suggests a common cause. Pierides et al' 0 suggested that the syndrome of encephalopathy and associated fractures may be due to phosphate depletion caused by aluminium hydroxide. But our results do not support this hypothesis.
We 
Summary
Two girls, aged 12 and 17 years, presented with hepatocellular dysfunction and severe haemolysis due to Wilson's disease (hepatolenticular degeneration). This was accompanied by acute renal failure. In the absence of renal function sufficient for the urinary excretion of penicillamine, studies were performed to assess the potential of peritoneal dialysis, ascites removal by ultrafiltration-reinfusion, and haemodialysis as alternative excretory pathways for copper. The greatest amount of copper, as judged by rising bath concentrations, seemed to be eliminated with haemodialysis. But this was accompanied by a progressive increase in serum copper concentrations with rapid clinical and biochemical deterioration leading to death within 48 hours. A small amount of copper was lost with ascites removal. Significant amounts of copper were removed during peritoneal dialysis (36 skmol/day (2287 Ftg/day) ), although a clinical response was not evident before haemodialysis was introduced. The administration of penicillamine orally, intravenously, or intraperitoneally produced no measurable increase in copper excretion into the peritoneal dialysate.
Hence peritoneal dialysis alone appears to offer the greatest potential benefit with regard to both eliminating copper and altering the course of this fulminant form of Wilson's disease. Haemolytic anaemia may precede these manifestations' and is usually brief. Rarely, however, when haemolysis occurs together with hepatic decompensation, rapid deterioration ensues if the condition is not diagnosed early. 2 We describe here two fatal cases of Wilson's disease. Both patients developed hepatic failure, severe haemolysis, and acute renal failure. Acute renal failure does not seem to have been reported before in association with Wilson's disease. Since the most effective chelating agent, penicillamine, is cleared from the plasma by the kidneys, peritoneal dialysis and haemodialysis were assessed in these patients as alternative means of eliminating the increased tissue copper stores. In addition, the role of penicillamine in the presence of renal insufficiency was evaluated in relation to peritoneal dialysis.
Case 1
This premenarchial 12-year-old girl experienced malaise with irritability and drowsiness 10 days before admission. Three days later profound anorexia developed with the passage of dark urine. She was feverish and had raised serum aspartate aminotransferase (SGOT) concentrations.
Over ihe next three days jaundice appeared, her level of consciousness deteriorated, and she was admitted to the Royal Victoria Infirmary. Examination showed scratch marks, chest acne, and red striae on breasts, abdomen, and thighs. Ascites was present but not hepatosplenomegaly. Melaena stools were being passed and she was anuric. The diagnosis of Wilson's disease was suggested by the presence of Kayser-Fleischer rings.
Investigations confirmed haemolytic anaemia with haemoglobin concentration of 8 7 g/dl, reticulocyte count of 34%, and reduced plasma haptoglobins. The Coombs test gave a negative result. The blood urea concentration was 13 2 mmol/l (79-5 mg/100 ml) (normal < 7 0 mmol/l (42 mg/100 ml) ). Prothrombin time was 36 s (control 13 s). Serum total bilirubin concentration was 1080 ,imol/l (63-2 mg/ 100ml) (normal <17 pLmol/l (0 99 mg/100 ml)), of which 800
